Sponsored Post: Recently, Jaguar Health, Inc. has announced that they had granted market options for the acquirement approx. 225,000 allotment under 2020 Inducement Plan. Looking for articles that could possibly help your venture? Consider this one. https://b.link/MostDemandBillionDollarEVsBatteryMarket In addition, these other industries are said to be a lithium brine exploration industry that engaged in exploring and developing resource properties. Check the disclaimer on the landing page.
Bullish
M
They’re not announcing the news during the meeting… it’s an annual stockholder voting session. “The adjourned meeting will be held at 8:30 a.m. Pacific Standard Time/11:30 a.m. Eastern Standard Time on Friday, June 11, 2021, at the offices of the Company at 200 Pine Street, Suite 400, San Francisco, CA 94104. The record date for determining stockholders eligible to vote at the Annual Meeting will remain the close of business on April 12, 2021. Stockholders have thus far strongly supported the proposals.”
A
now I am a bit undecided where to invest my 5k. ASXC or JAGX?? Both are showing a very positive future. Doubling this 5k is very much possible.
M
RELAX JAGX is burden with heavy shorting like so many other stocks. If you can't be patience stop trading stocks.
Bullish
M
Meeting 11.30 am... shorties watch out.
Bullish
s
How did 76% think doubling the amount of shares was a good idea and now they are holding out for more people to change their mind? I voted no, if it was a moderate share increase, yeah maybe it would get my vote. Sorry, just my opinion and I didn't see them taking any less compensation, so why would I agree to that large of a dilution.
Bullish
D
When we get European approval large medical company will want in. When that happens we are heading well over 20.00 a share.
T
don't get it why people sell at this price.
Bullish
B
yyyyyeeesssss 2$! congrats 👏
Bullish
M
I’m holding until 4 dollars
M
Award for most clever, intelligent, competent investor goes to… BLUE COLLAR INVESTING!! Congrats
W
Jagx wants so badly to have our approval to sell more stock because they know they have good news. 😊
Bullish
M
The more shorties the better... that means, theres a dip, time to buy. If everything was cheering here, and going up, i would think is time to sell :)
Bullish
B
Big News Coming soon :) 🚀😍
Bullish
K
I got 1,200 shares. I bought at 1.90. Holding long and strong.
M
Gimme +100%
Bullish
J
New PR
Jaguar Health & Dragon SPAC Announce Initial Funding of US$10.8 Million into Dragon SPAC
Napo EU S.p.A., named target of Dragon SPAC, provides update on plan to pursue conditional marketing authorization for crofelemer in EU
Equita Group S.p.A., a leading Italian based investment bank, advising Dragon SPAC; Cantor Fitzgerald & Co. advising Jaguar on non-deal related activities
San Francisco, CA & Milan, Italy (June 1, 2021): Jaguar Health, Inc. (“Jaguar”) and Milan, Italy-based Dragon SPAC S.p.A. (“Dragon SPAC”) today announced the initial funding of the private financing of Dragon SPAC, which has named as its target Napo EU S.p.A. (“Napo EU”). Dragon SPAC and Napo Pharmaceuticals, Inc. (“Napo Pharma”), Jaguar’s wholly-owned U.S. subsidiary, have entered into an agreement, pursuant to which Dragon SPAC will issue units (“Units”) to Napo Pharma in a private placement for cash consideration of approximately US$10.8 million, with proceeds of such financing to be used in part for Dragon SPAC’s contemplated business combination (the “Merger”) with Napo EU. Each Unit consists of one ordinary share of Dragon SPAC and one warrant. Each warrant will entitle the holder thereof to purchase one ordinary share at an exercise price of EUR 10 per ordinary share at any time prior to the earlier of (i) the 10-year anniversary of the consummation of the Merger and (ii) the five-year anniversary of the listing of the combined Napo EU/Dragon SPAC entity resulting from the Merger (the “Combined Company”) on a public exchange. The private financing is expected to close around the end of Q2 2021, subject to certain conditions including the concurrent closing of the Merger and completion of customary items.
Proceeds from the private placement will be used exclusively for the purposes of funding the Merger and the activities of the Combined Company.
Bullish
C
It’s always the patience get the money. I’m here since .56 and will never sell until 10! 🚀
H
Lets go baby. People roasted me of saying it going to$2. But my price target is still same thats $5 by july end
Recently, Jaguar Health, Inc. has announced that they had granted market options for the acquirement approx. 225,000 allotment under 2020 Inducement Plan. Looking for articles that could possibly help your venture? Consider this one. https://b.link/MostDemandBillionDollarEVsBatteryMarket In addition, these other industries are said to be a lithium brine exploration industry that engaged in exploring and developing resource properties. Check the disclaimer on the landing page.
If everything was cheering here, and going up, i would think is time to sell :)
Jaguar Health & Dragon SPAC Announce Initial Funding of US$10.8 Million into Dragon SPAC
Napo EU S.p.A., named target of Dragon SPAC, provides update on plan to pursue conditional marketing authorization for crofelemer in EU
Equita Group S.p.A., a leading Italian based investment bank, advising Dragon SPAC; Cantor Fitzgerald & Co. advising Jaguar on non-deal related activities
San Francisco, CA & Milan, Italy (June 1, 2021): Jaguar Health, Inc. (“Jaguar”) and Milan, Italy-based Dragon SPAC S.p.A. (“Dragon SPAC”) today announced the initial funding of the private financing of Dragon SPAC, which has named as its target Napo EU S.p.A. (“Napo EU”). Dragon SPAC and Napo Pharmaceuticals, Inc. (“Napo Pharma”), Jaguar’s wholly-owned U.S. subsidiary, have entered into an agreement, pursuant to which Dragon SPAC will issue units (“Units”) to Napo Pharma in a private placement for cash consideration of approximately US$10.8 million, with proceeds of such financing to be used in part for Dragon SPAC’s contemplated business combination (the “Merger”) with Napo EU. Each Unit consists of one ordinary share of Dragon SPAC and one warrant. Each warrant will entitle the holder thereof to purchase one ordinary share at an exercise price of EUR 10 per ordinary share at any time prior to the earlier of (i) the 10-year anniversary of the consummation of the Merger and (ii) the five-year anniversary of the listing of the combined Napo EU/Dragon SPAC entity resulting from the Merger (the “Combined Company”) on a public exchange. The private financing is expected to close around the end of Q2 2021, subject to certain conditions including the concurrent closing of the Merger and completion of customary items.
Proceeds from the private placement will be used exclusively for the purposes of funding the Merger and the activities of the Combined Company.